Tokyo, Japan

Kenichiro Hiwatari

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kenichiro Hiwatari: Innovator in Biocompatible Materials

Introduction

Kenichiro Hiwatari is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biocompatible materials, focusing on innovative methods for transplantation and curable compositions. His work has led to the development of two notable patents that showcase his expertise and creativity.

Latest Patents

Kenichiro Hiwatari holds two patents that reflect his innovative approach. The first patent is a method for producing decellularized material for transplantation. This method involves harvesting a branch-bearing blood vessel from a vertebrate animal, decellularizing the blood vessel, and adhering a portion where a branch has been excised to close the vessel through a protein denaturation treatment. The second patent is for a curable composition and cured article that offers excellent molding processability and high heat resistance. This composition is designed for use as a molding resin for silicon carbide power semiconductors.

Career Highlights

Kenichiro Hiwatari is associated with Adeka Corporation, where he has been able to apply his innovative ideas in a practical setting. His work has not only advanced the field of biocompatible materials but has also contributed to the development of new technologies in the industry.

Collaborations

Throughout his career, Kenichiro has collaborated with notable colleagues, including Atsuo Tomita and Tomoaki Saiki. These collaborations have further enriched his work and have led to advancements in their respective fields.

Conclusion

Kenichiro Hiwatari is a distinguished inventor whose contributions to biocompatible materials have made a significant impact in the field. His innovative patents and collaborations highlight his dedication to advancing technology and improving transplantation methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…